Biology

US pharmaceutical giants find themselves in a passive position as the government ignores lobbying efforts and continues to ease approval requirements for generic drugs.

The U.S. government announced on Wednesday that it will expedite the approval process for complex biosimilars and relax...

Stock
2026-01-12
Popular in
  1. Zhejiang Commercial Bank launched one of the first pilot program

    Articles
  2. Options Smart Investment Report: Large Options Orders Show Signs

    Articles
  3. A crucial battle! Musk drops a bombshell! Major shareholders opp

    Stock
  4. Tariffs loom large! Goldman Sachs raises its copper price foreca

    Stock